Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Front Immunol · 2022 · PMC9190258 · PMID 35707535

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although IL-2 therapy resulted in highly significant increases in CD4 counts, clinical endpoints were not improved and therapy had many side effects and was never pursued for clinical use ( 197 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.